Bilimsel çalışmalar

Prof. Dr. Cihan Uras

161 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Comparison of Tailor X and NSABP-20 regarding cost-effectiveness of recurrence score (RS®) for adjuvant chemotherapy decision in early-stage breast cancer

    BMC Health Services Research, 2026

    DOI 10.1186/s12913-026-15300-9 Kaynak: OpenAlex

  2. Absence of high-risk human papillomavirus in breast cancer tissues from young BRCA1/BRCA2-negative women

    BMC Women s Health, 2026

    DOI 10.1186/s12905-026-04494-z PMID 42057021 Açık erişimli tam metinKaynak: OpenAlex

  3. Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 1: Locoregional Therapy, Pathology, Radiology

    European Journal of Breast Health, 2026

    DOI 10.4274/ejbh.galenos.2026.2025-10-1 PMID 41873792 Açık erişimli tam metinKaynak: OpenAlex

  4. Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases

    Cancers, 2026

    DOI 10.3390/cancers18111760 PMID 42279343 Açık erişimli tam metinKaynak: OpenAlex

  5. Effect of Manual Lymph Drainage on Breast Edema After Breast-Conserving Surgery and Radiotherapy: A Preliminary Randomized Controlled Trial

    Cancers, 2026

    DOI 10.3390/cancers18101510 PMID 42192872 Açık erişimli tam metinKaynak: OpenAlex

  6. Concordance Between AI-generated Recommendations and Multidisciplinary Tumor Board Decisions in Postoperative Breast Cancer Management: A Retrospective Validation Study

    Turkish Journal of Surgical Oncology, 2026

    DOI 10.4274/turkjsurgoncol.galenos.2026.69885 Açık erişimli tam metinKaynak: OpenAlex

  7. Concomitant Cholecystectomy During Bariatric Surgery: Surgical Technique and Safety

    Journal of Laparoendoscopic & Advanced Surgical Techniques, 2026

    DOI 10.1177/10926429261491052 PMID 42802608 Kaynak: OpenAlex

  8. Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long‐Term Survival Update of a Prospective Multicenter Study in Türkiye According to Different Cut‐Offs

    World Journal of Surgery, 2025

    DOI 10.1002/wjs.70025 PMID 40751287 Kaynak: OpenAlex

  9. Association of Mitochondrial DNA Copy Number Variations with Triple-Negative Breast Cancer: A Potential Biomarker Study

    Diseases, 2025

    DOI 10.3390/diseases13060175 PMID 40558586 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  10. De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer

    JAMA Surgery, 2025

    DOI 10.1001/jamasurg.2024.5913 PMID 39745737 28 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  11. Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

    Current Oncology, 2025

    DOI 10.3390/curroncol32100556 PMID 41149476 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  12. ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03

    Annals of Surgical Oncology, 2025

    DOI 10.1245/s10434-024-16746-z PMID 39964563 Kaynak: OpenAlex

  13. Comparison of Clinicopathologic Features and Survival Outcomes of Pleomorphic Lobular, Classical Lobular, and Invasive Ductal Carcinoma

    World Journal of Surgery, 2025

    DOI 10.1002/wjs.12589 PMID 40252206 Kaynak: OpenAlex

  14. Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study

    British journal of surgery, 2025

    DOI 10.1093/bjs/znaf180 PMID 40966675 1 atıf (Europe PMC) Kaynak: OpenAlex

  15. Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

    European Journal of Surgical Oncology, 2025

    DOI 10.1016/j.ejso.2025.109642 PMID 40009910 5 atıf (Europe PMC) Kaynak: OpenAlex

  16. Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study

    Clinical Breast Cancer, 2025

    DOI 10.1016/j.clbc.2025.02.002 PMID 40055044 1 atıf (Europe PMC) Kaynak: OpenAlex

  17. Relationships Between Breast Edema and Axillary Lymph Node Metastasis in Breast Cancer

    Diagnostics, 2025

    DOI 10.3390/diagnostics15111300 PMID 40506872 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  18. Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye

    European Journal of Public Health, 2025

    DOI 10.1093/eurpub/ckaf108 PMID 40628383 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  19. Comparison of Early Results of Laparoscopic Transabdominal Preperitoneal and Total Extraperitoneal Repair in Recurrent Inguinal Hernia

    Journal of Laparoendoscopic & Advanced Surgical Techniques, 2025

    DOI 10.1089/lap.2025.0067 PMID 40495725 1 atıf (Europe PMC) Kaynak: OpenAlex

  20. Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry Study

    Asian Pacific Journal of Cancer Prevention, 2025

    DOI 10.31557/apjcp.2025.26.12.4407 PMID 41459855 Açık erişimli tam metinKaynak: OpenAlex

  21. P044: Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey

    The Breast, 2025

    DOI 10.1016/j.breast.2025.103928 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  22. Abstract P2-03-14: PATIENT REPORTED OUTCOMES AND LYMPHEDEMA IN NODE-POSITIVE BREAST CANCER IN THE EARLY POSTOPERATIVE PERIOD AFTER NEOADJUVANT CHEMOTHERAPY IN THE PROSPECTIVE NEOSENTITURK-trial MF18-03

    Clinical Cancer Research, 2025

    DOI 10.1158/1557-3265.sabcs24-p2-03-14 Kaynak: OpenAlex

  23. Abstract P4-06-06: The Etiologic Causes of Diagnostic Delay in Locally Advanced Breast Cancer: _x000B_A Multicentric Nationwide Trial

    Clinical Cancer Research, 2025

    DOI 10.1158/1557-3265.sabcs24-p4-06-06 Kaynak: OpenAlex

  24. Abstract P3-07-10: Omitting axillary dissection in Triple-negative and HER2-overexpressed cancers After neoadjuvant Chemotherapy: OTHER-NAC Study

    Clinical Cancer Research, 2025

    DOI 10.1158/1557-3265.sabcs24-p3-07-10 Kaynak: OpenAlex

  25. Abstract P3-07-14: Omitting axillary dissection in Triple-negative and HER2-overexpressed breast cancers with positive sentinel Lymph nOdes during upfront surgery: OTHELLO Study

    Clinical Cancer Research, 2025

    DOI 10.1158/1557-3265.sabcs24-p3-07-14 Kaynak: OpenAlex

  26. Utilization of Serratus Muscle-Fascia Flap to Ensure Implant Stability in Prepectoral Direct-to-Implant Reconstruction

    Aesthetic Plastic Surgery, 2025

    DOI 10.1007/s00266-025-05238-4 PMID 41023234 Kaynak: OpenAlex

  27. Positive anti-TG antibody is associated with increased breast cancer risk in Turkish peri-postmenopausal women: A retrospective study

    Research Square, 2024

    DOI 10.21203/rs.3.rs-4673282/v1 Açık erişimli tam metinKaynak: OpenAlex

  28. Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided

    Cancer, 2024

    DOI 10.1002/cncr.35610 PMID 39476303 13 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  29. Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03

    Annals of Surgical Oncology, 2024

    DOI 10.1245/s10434-024-16472-6 PMID 39623189 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  30. Abstract PS01-01: Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study

    Cancer Research, 2024

    DOI 10.1158/1538-7445.sabcs23-ps01-01 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  31. Abstract PO5-05-12: Loco-regional Treatment in De Novo Bone Only Metastatic Breast Cancer; Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

    Cancer Research, 2024

    DOI 10.1158/1538-7445.sabcs23-po5-05-12 Kaynak: OpenAlex

  32. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.24.01052 PMID 39509672 44 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  33. Kinesiophobia, physical activity levels and barriers in breast cancer patients, survivors, and healthy controls: a case-control analysis

    Journal of the Pakistan Medical Association, 2024

    DOI 10.47391/jpma.10558 PMID 39160708 4 atıf (Europe PMC) Kaynak: OpenAlex

  34. ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered

    Annals of Surgical Oncology, 2024

    DOI 10.1245/s10434-024-16651-5 PMID 39653946 1 atıf (Europe PMC) Kaynak: OpenAlex

  35. A New Convenient Incision Model of the Nipple-Sparing Mastectomy: Lateralized Parabolic Multiplanar Incision

    Aesthetic Plastic Surgery, 2024

    DOI 10.1007/s00266-024-04115-w PMID 38769149 1 atıf (Europe PMC) Kaynak: OpenAlex

  36. Unmet Needs of Breast Cancer Survivors and Related Factors: A Cross-Sectional Study

    Research Square, 2024

    DOI 10.21203/rs.3.rs-5379884/v1 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  37. Abstract PO1-22-03: Radiation Toxicity and Treatment Outcomes in Breast Cancer Patients with ATM Pathogenic and VUS Mutations: Implications for Personalized Therapy

    Cancer Research, 2024

    DOI 10.1158/1538-7445.sabcs23-po1-22-03 Kaynak: OpenAlex

  38. What Do Breast Cancer Previvors Tell Us About Their Stories? To Know or Not to Know?

    Seminars in Oncology Nursing, 2024

    DOI 10.1016/j.soncn.2024.151714 PMID 39164159 Kaynak: OpenAlex

  39. Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey

    Frontiers in Oncology, 2023

    DOI 10.3389/fonc.2023.1151733 PMID 37448522 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  40. Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization

    European Journal of Breast Health, 2023

    DOI 10.4274/ejbh.galenos.2023.2023-8-5 PMID 37795003 Açık erişimli tam metinKaynak: OpenAlex

  41. Abstract P2-11-31: FAVORABLE LOCOREGIONAL CONTROL IN CLINICALLY NODE-NEGATIVE HORMONE-RECEPTOR POSITIVE BREAST CANCER WITH LOW 21-GENE RECURRENCE SCORES: A SINGLE INSTITUTIONAL STUDY WITH 10-YEAR FOLLOW-UP

    Cancer Research, 2023

    DOI 10.1158/1538-7445.sabcs22-p2-11-31 1 atıf (OpenAlex) Kaynak: OpenAlex

  42. False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.60973 Kaynak: OpenAlex

  43. Abstract PD15-01: PD15-01 AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03

    Cancer Research, 2023

    DOI 10.1158/1538-7445.sabcs22-pd15-01 Açık erişimli tam metinKaynak: OpenAlex

  44. Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacy

    Frontiers in Medicine, 2023

    DOI 10.3389/fmed.2023.1251851 PMID 37859855 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  45. Sentinel lymph node biopsy after nipple-sparing mastectomy in early postoperative period: Is it feasible?

    Indian Journal of Cancer, 2023

    DOI 10.4103/ijc.ijc_1175_20 PMID 37530247 2 atıf (Europe PMC) Kaynak: OpenAlex

  46. Direct to Implant versus 2-Stage Expander Implant Immediate Breast Reconstruction: Comparison of Incidence and Predictors of Complications

    Acibadem Universitesi Saglik Bilimleri Dergisi, 2023

    DOI 10.31067/acusaglik.1291793 Kaynak: OpenAlex

  47. Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors

    Supportive Care in Cancer, 2023

    DOI 10.1007/s00520-023-07742-2 PMID 37079089 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  48. Implant selection in natural and stable direct-to-implant reconstruction with ten steps at nipple-sparing mastectomy

    Medicine, 2023

    DOI 10.1097/md.0000000000033758 PMID 37171305 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  49. Turkish Validity and Reliability Study of Breast Cancer Self-Efficacy Survivor Scale

    Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 2023

    DOI 10.37989/gumussagbil.1320681 Kaynak: OpenAlex

  50. Comparison of mammography and ultrasound findings in the follow-up of patients with breast cancer treated with segmental mastectomy followed by intraoperative electron radiotherapy versus external whole breast radiotherapy

    Diagnostic and Interventional Radiology, 2023

    DOI 10.4274/dir.2023.211218 PMID 36994946 Açık erişimli tam metinKaynak: OpenAlex